MarginsXMarginsX
Home › Markets › Health Care › PDSB

PDS Biotechnology Corporation (PDSB)

PDSB trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$0.9241
+5.90% on the day
Market cap
$113.4M
Micro cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026.

Profile

FieldValue
TickerPDSB on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO year2015
SEC CIK0001472091
SEC industry codePharmaceutical Preparations
Incorporated inDE

Financials

Not reported in SEC XBRL data.

Warning signs

Cash runway
4.0 months
$5.6M cash at June 30, 2026
Share count, 1 year
+20.0%
2025-08-06 to 2026-08-06 · +81.3% over 3 years
Going-concern doubt
Yes
10-Q filed August 13, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"As a result of these uncertainties, the Company has concluded that substantial doubt exists about the Company's ability to continue as a going concern for a period of at least 12 months from the date of the issuance of these unaudited Condensed Consolidated Financial Statements."
10-Q 2026-08-13
Cash and burn$5.6M cash; operating cash flow -$4.2M a quarter.Report 2026-06-30
Shares outstanding55,971,338 (2026-08-06); 46,633,362 a year earlier; 30,868,188 three years earlier.Cover page 2026-08-06
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months2 S-3/F-3 shelf filings; 1 424B5 takedowns, 1 at the marketLatest 2026-06-15
Exchange deficiency notices, 12 months2 (8-K item 3.01)8-K 2026-07-31
AuditorKPMG LLP, Short Hills, New Jersey, United StatesPCAOB Form AP 2026-04-30
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30
Market cap checkThe listing's market cap implies 122,704,544 shares at the 2026-11-13 price; the latest SEC cover count is 55,971,338 as of 2026-08-06. One of the two share counts is stale.Nasdaq screener and SEC cover page

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
Not filed-$9.8M-$2.8M$5.6MNo debt tagsNeeds four quarters10-Q 2026-08-13
Q1 2026
2026-03-31
Not filed-$7.3M-$4.4M$21.7MNo debt tagsNeeds four quarters10-Q 2026-08-13
Q4 2025
2025-12-31
Not filed-$7.6M-$3.7M$26.7MNo debt tagsNeeds four quarters10-K 2026-03-30
Q3 2025
2025-09-30
Not filed-$9.0M-$5.9M$26.2MNo debt tagsNeeds four quarters10-K 2026-03-30
Q2 2025
2025-06-30
Not filed-$9.4M-$9.1M$31.9MNo debt tagsNeeds four quarters10-Q 2026-08-13
Q1 2025
2025-03-31
Not filed-$8.5M-$9.0M$40.0MNo debt tagsNeeds four quarters10-Q 2026-08-13
Q4 2024
2024-12-31
Not filed-$8.0M-$8.2M$41.7MNo debt tagsNeeds four quarters10-K 2026-03-30
Q3 2024
2024-09-30
Not filed-$10.7M-$8.0M$49.8MNo debt tagsNeeds four quarters10-K 2026-03-30

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentS-32026-10-14
Latest annual report10-K/A2026-04-28
Latest quarterly / interim10-Q2026-11-16
Latest current report8-K2026-11-13
Latest proxyDEFA14A2026-06-26

Source: SEC EDGAR submissions feed, 799 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-29.0%
1 month-45.4%
3 months+274.7%
Year to date+13.4%
1 year+3.3%
From 52-week high-45.4%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
IMUXImmunic Inc.$7.23-3.86%$114.8M
CATXPerspective Therapeutics Inc.$0.9238-2.05%$111.6M
OKUROnKure Therapeutics Inc.$2.75+4.56%$111.4M
NERVMinerva Neurosciences Inc$2.20-4.35%$109.6M
UPBUpstream Bio Inc.$2.15-22.66%$117.8M
FHTXFoghorn Therapeutics Inc.$1.79-13.53%$107.3M
BGMBGM Group Ltd.$8.01+1.71%$107.0M
SPRBSpruce Biosciences Inc.$42.25-2.45%$121.4M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier